Subtotal $0.00
- +91 98917 72228
- servicesmaxhealthcare@gmail.com
- New Delhi, India
Ken serves as the President and Chief Executive Officer of Bell Biosystems, and has previously served on the Boards of Cesca Therapeutics (Nasdaq: KOOL), TotipotentRX Corporation and MK Alliance, Inc., both which he co-founded and successfully exited. Ken has held multiple senior Fortune 100/500 roles including Corporate Senior Vice President and Business Unit President for Pall Life Sciences’ (NYSE: PALL) cellular therapy, diagnostic and research divisions.
Prior to joining CCRM as COO, Mitch led operations, manufacturing, development, and commercial departments at Cesca Therapeutics, Inc. (Nasdaq: KOOL), located in Rancho Cordova, California. While at Cesca, Mitch managed a global employee base (U.S., EU, India, China) involved in all aspects of regenerative medicine-based software, controlled electromechanical devices and companion disposables for therapeutic use in Intraoperative Orthopedics (Spine & Non-Unions) & Hematology/Oncology Markets (BMT, Cord Blood).
Founder Director of Medsolin having 18+years of technical business development experience in regenerative medicine and healthcare services. Always eager to learn with a proven track record of deliverables and testimonials. Sandy is a genetic engineer turned entreprenuer. Has keen interest is in knowing about different cultures especially SEA / African region and in an avid traveler to these regions.
One Stop Solution | Unmatched Quality Care | Clear Communication
Achievement
Our team of dedicated healthcare professionals combines years of experience with a genuine commitment to providing
Your health and well-being are our top priorities. We take the time to listen to your concerns, answer your questions.
We understand that every patient is unique, and their healthcare needs may vary. That's why we create individualized treatment.
“Objectively deploy open-source web-readiness impactful bandwidth. Compellingly coordinate business deliverables rather equity invested technologies. Phosfluorescently reinvent maintainable.”
“Objectively deploy open-source web-readiness impactful bandwidth. Compellingly coordinate business deliverables rather equity invested technologies. Phosfluorescently reinvent maintainable.”
“Objectively deploy open-source web-readiness impactful bandwidth. Compellingly coordinate business deliverables rather equity invested technologies. Phosfluorescently reinvent maintainable.”
“Objectively deploy open-source web-readiness impactful bandwidth. Compellingly coordinate business deliverables rather equity invested technologies. Phosfluorescently reinvent maintainable.”
